What does it take to support partnering for life sciences on a scale as large and intensive as BioPharm America™ 2008? The partneringONE™ software from EBD Group, which begins to virtually connect BioPharm America participants six weeks ahead of the event.
Then, during the two days in Atlanta, it all comes together in the real Read more »
A recent piece in the Financial Times suggests that pharma’s drying drug pipelines are the result of a “mis-measure of uncertainty as academic researchers underestimated the fragility of their scientific knowledge while pharmaceutical executives overestimated their ability to domesticate scientific research.”
Read the full article here
Read more »
In the recent edition of Pullan Pieces, biotech business development consultant Linda M. Pullan notes the rebound for partnering in the second quarter of this year and then sharpens her focus on the real deals being done.
The following extract is a special feature for Partnering News:
According to Burrill, partnering in the 2nd quarter of 2008 Read more »
BioPharm America™ attending company, Symphogen A/S, announced two partnership deals ahead of the summer vacation that leave the company strongly positioned for the start of business-as-usual in September.
Symphogen announced in June a global strategic collaboration with Genentech, Inc. for antibody therapeutics against three undisclosed infectious disease targets.
In the partnership, Symphogen will apply its proprietary Symplex™ Read more »
In partnership with Hospira, Inc, Altea Therapeutics will develop an as yet undisclosed product using the Altea’s proprietary PassPort™ Transdermal Delivery System.
Under the terms of the agreement, Altea Therapeutics will fund certain Phase 1 clinical studies after which Hospira will fund all further product development, manufacturing, and commercialization activities. Altea Therapeutics has granted Hospira exclusive Read more »
The ivory towers of Heidelberg meet the Mannheim steamroller of big business for the 14th edition of BIO-Europe, set for Nov. 17 to 19, 2008 at the Congress Center Mannheim.
International pharmaceutical, biotechnology and academic leaders will be joined in this partnering meeting with the prestigious German institutes, leading pharmaceutical companies and numerous biotech Read more »
“Our claim to fame is making connections,” says John Richert at the North Carolina Biotechnology Center, who is the key contact as Vice President for Business and Technology Development for America’s third-largest biotechnology cluster.
Setting up 30 partnering meetings for a visiting company is one of the most active, and practical examples of what Richert Read more »
Biotech is booming in Georgia, and while the explosive growth of biofuel technologies grabs headlines, the growth in life science biotechnology is no less aggressive, thanks to the determination to mobilize resources towards expanding this sector of the State’s economy.
Carol Henderson, the Director of the Innovation & Technology Office at the Georgia Department of Economic Read more »
Newsletter